Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury

生物能衰竭是围产期脑损伤后脑功能障碍的基础

基本信息

  • 批准号:
    10240636
  • 负责人:
  • 金额:
    $ 39.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY ABSTRACT Long-term cognitive impairment and learning disabilities are a major public health concern that affects more than half of infants born very preterm with immature lung injury. Such infants have a global delay in cerebral maturation of gray and white matter structures, likely caused by high susceptibility to hypoxia-induced oxidative stress during this critical period. This stress can result in mitochondrial dysfunction. If mitochondrial-dependent oxidative metabolism is required for immature progenitor cells to mature, then mitochondrial dysfunction can result in failure of timely progenitor cell maturation. Little is known about the metabolic alterations or the dependence of neural progenitor cell maturation on mitochondrial metabolism in the developing brain. Our work will fill this gap in knowledge. We use a rodent model of chronic hypoxia to recapitulate the immature lung injury commonly found in very preterm infants, which causes global gray and white matter cellular dysmaturity and associated ultrastructural and behavioral deficits. In this study, we will investigate the metabolic effects of hypoxia on hippocampal dysmaturation and determine the developmental outcome of mitochondrial disruption. Our preliminary data on the hippocampus indicate that: i) hypoxia causes long-term decreases in biochemical markers of mitochondrial function; ii) hypoxia impairs expression of pyruvate dehydrogenase E1α independent of its inhibitors; and iii) conditional removal of pyruvate dehydrogenase E1α from GFAP-expressing radial glia stem cells prevents their maturation. A potential target for promoting recovery after perinatal brain injury is timely restoration of mitochondrial function and oxidative metabolism. Our published and preliminary data strongly suggest the novel findings that intranasal heparin-binding epidermal growth factor [HB-EGF] treatment after hypoxia may reverse hypoxia-induced cellular dysmaturation, restore mitochondrially produced N-acetyl aspartate, and ameliorate neurobehavioral deficits by targeting the mitochondria. We hypothesize that mitochondrial dysfunction results in delayed development of hippocampal neural progenitor cell capacity to perform oxidative energy metabolism, thus preventing their maturation. We will test the hypothesis that restoring mitochondrial function will enable these cells to meet their bioenergetic demands, permitting timely cellular maturation and recovery of function in the hippocampus. These hypotheses will be tested in three specific aims. In Aim 1, we will determine whether hypoxia impairs mitochondrial function in the hippocampus. In Aim 2, we will determine whether hypoxia or cell-specific removal of pyruvate dehydrogenase E1α in hippocampal neural progenitor cells delays differentiation and hippocampal behavioral deficits. In Aim 3, we will determine whether intranasal HB-EGF treatment after hypoxia enhances mitochondrial function. Successful completion of these aims will elucidate a fundamental biochemical mechanism that determines differentiation failure of neural progenitor cells after hypoxia-induced injury and define a novel metabolic mechanism by which HB-EGF facilitates cellular and functional recovery after neonatal brain injury.
项目摘要 长期认知障碍和学习障碍是一个主要的公共卫生问题, 超过一半的早产儿有不成熟的肺损伤。这类婴儿的大脑发育全面延迟, 灰色和白色物质结构的成熟,可能是由于对缺氧诱导的氧化 在这个关键时期的压力。这种压力可导致线粒体功能障碍。如果是依赖性的 氧化代谢是未成熟祖细胞成熟所必需的,那么线粒体功能障碍可以 导致祖细胞不能及时成熟。关于代谢改变或 神经前体细胞成熟对发育中大脑线粒体代谢的依赖性。我们 工作将填补这一知识空白。我们使用慢性缺氧的啮齿动物模型来重现未成熟的肺 损伤常见于极早产儿,导致整体灰质和白色质细胞发育不良 以及相关的超微结构和行为缺陷。在这项研究中,我们将研究代谢的影响, 缺氧对海马发育不良的影响,并确定线粒体破坏的发育结果。 我们对海马体的初步数据表明:i)缺氧导致生物化学的长期下降, 线粒体功能标志物; ii)缺氧损害丙酮酸脱氢酶E1α非依赖性表达 其抑制剂;和iii)从表达GFAP的放射状神经胶质细胞中有条件地去除丙酮酸脱氢酶E1α 干细胞阻止它们成熟。促进围产期脑损伤后恢复的一个潜在靶点是 及时恢复线粒体功能和氧化代谢。我们公布的和初步的数据 强烈提示鼻内肝素结合表皮生长因子[HB-EGF]治疗 缺氧后可逆转缺氧诱导的细胞发育不良, 天冬氨酸,并通过靶向线粒体改善神经行为缺陷。我们假设 线粒体功能障碍导致海马神经前体细胞发育延迟, 进行氧化能量代谢,从而阻止它们的成熟。我们将检验这个假设, 恢复线粒体功能将使这些细胞能够满足其生物能量需求, 海马体中的细胞成熟和功能恢复。这些假设将在三个测试 明确的目标。在目标1中,我们将确定缺氧是否损害海马线粒体功能。 在目标2中,我们将确定是否缺氧或细胞特异性去除丙酮酸脱氢酶E1α, 海马神经祖细胞延迟分化和海马行为缺陷。在目标3中,我们 将确定缺氧后鼻内HB-EGF治疗是否增强线粒体功能。 成功完成这些目标将阐明一个基本的生化机制, 缺氧诱导损伤后神经前体细胞的分化失败,并定义了一种新的代谢 HB-EGF促进新生儿脑损伤后细胞和功能恢复的机制。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Age-Dependent Cellular and Behavioral Deficits Induced by Molecularly Targeted Drugs Are Reversible.
  • DOI:
    10.1158/0008-5472.can-17-2254
  • 发表时间:
    2018-04-15
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Scafidi J;Ritter J;Talbot BM;Edwards J;Chew LJ;Gallo V
  • 通讯作者:
    Gallo V
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Scafidi其他文献

Joseph Scafidi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Scafidi', 18)}}的其他基金

Coordination of fatty acid metabolism following neonatal brain injury from preterm birth
早产新生儿脑损伤后脂肪酸代谢的协调
  • 批准号:
    10641924
  • 财政年份:
    2022
  • 资助金额:
    $ 39.19万
  • 项目类别:
Coordination of fatty acid metabolism following neonatal brain injury from preterm birth
早产新生儿脑损伤后脂肪酸代谢的协调
  • 批准号:
    10539030
  • 财政年份:
    2022
  • 资助金额:
    $ 39.19万
  • 项目类别:
Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury
生物能衰竭是围产期脑损伤后脑功能障碍的基础
  • 批准号:
    10328820
  • 财政年份:
    2017
  • 资助金额:
    $ 39.19万
  • 项目类别:
Mechanisms regulating KCC2 hypofunction during refractory seizures in a mouse model of ischemic neonatal seizures
缺血性新生儿癫痫发作小鼠难治性癫痫发作期间 KCC2 功能低下的调节机制
  • 批准号:
    10205121
  • 财政年份:
    2017
  • 资助金额:
    $ 39.19万
  • 项目类别:
Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury
生物能衰竭是围产期脑损伤后脑功能障碍的基础
  • 批准号:
    9382739
  • 财政年份:
    2017
  • 资助金额:
    $ 39.19万
  • 项目类别:
Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury
生物能衰竭是围产期脑损伤后脑功能障碍的基础
  • 批准号:
    9752675
  • 财政年份:
    2017
  • 资助金额:
    $ 39.19万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    9098869
  • 财政年份:
    2015
  • 资助金额:
    $ 39.19万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    8091982
  • 财政年份:
    2011
  • 资助金额:
    $ 39.19万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    8436277
  • 财政年份:
    2011
  • 资助金额:
    $ 39.19万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    8233981
  • 财政年份:
    2011
  • 资助金额:
    $ 39.19万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了